Slipped Capital Femoral Epiphysis Associated with Endocrinopathy: A Narrative Review.

Slipped capital femoral epiphysis (SCFE) has a well-documented association with underlying endocrine conditions, including thyroid hormone aberrations and parathyroid dysfunction. Recombinant growth hormone therapy has also been identified as a risk factor for the development of SCFE. Presentation before their 10th birthday or after their 16th birthday along with height of <10th percentile are reliable risk factors for identifying children with an SCFE who are at a heightened risk for an underlying endocrinopathy and can been used to guide selective laboratory testing. Patients with unilateral SCFE presentations with an underlying endocrinopathy are at a heightened risk for contralateral slip development and should be treated with prophylactic fixation. Copyright © 2022 by The Journal of Bone and Joint Surgery, Incorporated.

Citation

K Aaron Shaw, A Luke Shiver, Tannur Oakes, Nicholas D Fletcher. Slipped Capital Femoral Epiphysis Associated with Endocrinopathy: A Narrative Review. JBJS reviews. 2022 Feb 07;10(2)

Mesh Tags

PMID: 35130197

search → result